What are the differences between herpes simplex virus type 1 (HSV‑1) and herpes simplex virus type 2 (HSV‑2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Key Differences Between HSV-1 and HSV-2

HSV-1 and HSV-2 are distinct viral types that differ fundamentally in their anatomical site preferences, recurrence patterns, and transmission characteristics, though both can cause genital and oral infections. 1

Anatomical Site Preference

  • HSV-1 primarily causes oral infections but is increasingly responsible for genital herpes, particularly in well-resourced settings where it now accounts for at least 50% of new genital herpes cases 1, 2
  • HSV-2 nearly exclusively causes genital disease and is rarely associated with oral infection 1
  • HSV-1 is traditionally isolated from the upper body (innervated by trigeminal ganglia), while HSV-2 is isolated from the lower body (innervated by sacral ganglia) 3

Neuronal Latency Patterns

The viruses establish latency in different neuronal populations, which explains their distinct reactivation patterns:

  • HSV-1 preferentially establishes latency in A5-positive neurons (25% of HSV-1 latency-associated transcript-expressing neurons) 4
  • HSV-2 preferentially establishes latency in KH10-positive neurons (42% of HSV-2 latency-associated transcript-expressing neurons) 4
  • This neuronal preference is influenced by the latency-associated transcript (LAT) regions of each virus type 4

Recurrence Frequency

  • HSV-2 causes more frequent genital recurrences than genital HSV-1 infection 2
  • After intranasal inoculation in animal models, HSV-1 produces higher frequency of latent infection in trigeminal ganglia, while HSV-2 shows higher frequency in lumbosacral ganglia after intravaginal inoculation 5

Neurovirulence and CNS Involvement

  • HSV-2 demonstrates enhanced capacity to enter and replicate in the central nervous system in animal models, producing higher death rates across multiple routes of infection 5
  • HSV-1 is the primary cause of herpes simplex encephalitis in clinical practice 6
  • HSV-2 is associated with aseptic meningitis more commonly than HSV-1 1

Viral Receptor Interactions

The two types interact differently with cellular receptors:

  • Both viruses use heparan sulfate (HS) as an initial receptor, but they recognize different structural features of HS 7
  • HSV-1 requires 6-O sulfations and 2-,3-O sulfations for optimal infection, while HSV-2 infection is less dependent on these O-sulfations 7
  • The envelope glycoproteins, particularly glycoprotein C, differ between types and mediate these distinct receptor interactions 7

Antigenic Differences

  • Glycoprotein G (gG) provides the most reliable type-specific antigenic distinction, with gG-1 and gG-2 containing relatively long type-unique amino acid stretches 8
  • These antigenic differences enable type-specific serological testing, which is clinically important for diagnosis, counseling, and management decisions 1, 8

Epidemiology and Prevalence

  • HSV-1 seroprevalence is 47.8% in the US population aged 14-49 years, reflecting both oral and genital infections 1
  • HSV-2 seroprevalence is 12.1% in the same population 1
  • Globally in 2020, there were an estimated 519.5 million prevalent HSV-2 infections and 376.2 million prevalent genital HSV-1 infections in people aged 15-49 years 9

Transmission and Replication Patterns

  • HSV-1 replicates to higher titers in vaginal mucosa in animal models, but HSV-2 produces higher death rates and greater frequency of latent infection in lumbosacral ganglia 5
  • In mixed infections (which occur in approximately 4% of cases), the genome ratio reflects organ preference: HSV-1 dominates in ocular infections (100:1 ratio), while HSV-2 dominates in genital infections (4-40:1 ratio) 3

Clinical Implications

  • Both viruses cause clinically similar acute genital ulcer disease, making laboratory confirmation essential for type-specific diagnosis 1, 10
  • Only 13% of HSV-2 seropositive persons have been diagnosed with genital herpes, indicating most infections are unrecognized 1
  • Type-specific diagnosis is important for counseling regarding recurrence frequency, transmission risk, and management strategies 1, 10

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.